In the midst of the coronavirus pandemic, CV Sciences, a hemp CBD manufacturer based in San Diego, reported revenue of $8.3 million for the first quarter ended March 31, down 45% from the same period a year ago.
Coronavirus pandemic, absence of regulation cause CV Sciences to ‘right-size operations’ as first quarter sales suffer is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
From Coronavirus pandemic, absence of regulation cause CV Sciences to ‘right-size operations’ as first quarter sales suffer on CBD Products & CBD Business News – Hemp Industry Daily.
This was autoposted by IFTTT. To find out more, read my post about news articles.
No comments:
Post a Comment